ScholarIQanswers from OpenAlex

The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells

PaperCitations, authors & open-access status

The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells have?

ScholarIQcitation count

The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells has 80 citations in the OpenAlex counts ScholarIQ stores.

When was The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells published?

ScholarIQyear

The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells has 2014 year in the ScholarIQ index.

What is the open-access status of The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells?

ScholarIQoa status

The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells has diamond oa status in the ScholarIQ index.

What is the DOI of The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells?

ScholarIQdoi

The DOI for The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells is on the source record.

What is the PMID of The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells?

ScholarIQpmid

The PMID for The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells is on the source record.

What is the OpenAlex record for The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells?

ScholarIQopenalex

The OpenAlex for The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial